Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes. - Wikidata - awgldk - TriplyDB

Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes.

Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes.

http://www.wikidata.org/entity/Q37875220

about

The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes.Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes.Cardiovascular effects of gliptins.Cardiovascular effects of dipeptidyl peptidase-4 inhibitors: from risk factors to clinical outcomes.Effects of sulfonylureas on lipids in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.Effects of insulin monotherapy on body weight, composition, and fat distribution in newly diagnosed patients with Type 2 diabetes mellitus.Basal-bolus insulin therapy reduces maternal triglycerides in gestational diabetes without modifying cholesteryl ester transfer protein activity.Treatment of Dyslipidemia in Diabetes: Recent Advances and Remaining Questions.Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials.

P2860

Q33771752-D3A1A93A-E0E0-457E-8C6D-21FF9D863254 Q35044151-9720937E-E64F-4264-9EBA-B4616F6D3323 Q38072259-634E4AA9-FB37-4F6A-BC81-F688F8A412CF Q38113092-CA869BEB-C31B-47E7-BE3A-B7F978494808 Q40844288-D4D1179A-9892-402F-A7BA-DFF1E693393D Q45794720-839DB4B7-D1B0-44FC-B5CA-8AFCBAF65C0F Q47838701-A3F43E25-8E36-44C2-8D3C-02EF15386068 Q49689988-476AB806-8CFB-45E8-9192-0EB80DB2DF96 Q51597934-531AD80C-DBE5-434F-830C-D24CFC337D6F

P2860

Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes.

http://www.wikidata.org/entity/Q37875220

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effects of insulin and other a ...... les of patients with diabetes.

@en

Effects of insulin and other a ...... les of patients with diabetes.

@nl

type

label

Effects of insulin and other a ...... les of patients with diabetes.

@en

Effects of insulin and other a ...... les of patients with diabetes.

@nl

prefLabel

Effects of insulin and other a ...... les of patients with diabetes.

@en

Effects of insulin and other a ...... les of patients with diabetes.

@nl

P1433

Q37875220-DBB71AA6-C1B6-4C08-BB3E-2963C288889C

P1476

Q37875220-85A99ADB-0E1F-4D6D-8BA6-97663283BA61

P2093

Q37875220-54C03D10-C944-47E9-A2CC-D7DA5FD0B838

Q37875220-CFE03F10-3BED-466A-AD90-8730C6A31916

P2860

Q37875220-010F08B7-E054-40A2-AE0B-C3281049ED9B

Q37875220-0130A09E-10B6-49C2-8D5A-7C8E5C593D94

Q37875220-038BA225-EEFD-4566-BEF0-12E0552B4F40

Q37875220-03DDDDAA-7F91-4CCF-8973-B9C2E8946FC7

Q37875220-03E599C7-540F-4C8B-A1F5-39E99717769C

Q37875220-0CF66049-51FE-4392-810A-AA0DBB228047

Q37875220-0FD7B78E-FB4C-482C-A84C-85B5E96B39F5

Q37875220-103BBF79-C603-471B-8A4D-E4B4773B68F3

Q37875220-11A33487-65E3-4D70-97AC-E3233689EBDC

Q37875220-154F0F51-F134-48C1-8C69-2A3E330D622D

P304

Q37875220-CB14BFB9-FF7E-4C3B-9536-5F96300C8DF1

P31

Q37875220-3655753B-6B1D-4E43-9BDA-AD33CB1E7156

P356

Q37875220-118A6BA1-8CC5-4F5F-8311-F2ED6E16D41C

P433

Q37875220-78810561-0C28-47F9-B40B-FCC96316EFD7

P478

Q37875220-145C3092-2EF1-40F8-916C-A8FCE827797F

P577

Q37875220-0783BD3F-AF11-4162-974D-2C33D16344B4

P698

Q37875220-65EE51C2-4591-4C8B-976D-82AB98637E50

P921

Q37875220-22A860DD-F09F-4076-A5E6-0A5B5632E372

P356

J.1463-1326.2011.01423.X

P1433

Diabetes, Obesity and Metabolism

P1476

Effects of insulin and other a ...... les of patients with diabetes.

@en

P2093

A Chaudhuri

http://www.w3.org/2001/XMLSchema#string

P Dandona

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

Role of AMP-activated protein kinase in mechanism of metformin action

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

P304

869-879

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1463-1326.2011.01423.X

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21569185

http://www.w3.org/2001/XMLSchema#string

P921